151
Views
24
CrossRef citations to date
0
Altmetric
Review

Risk of morbidity in contemporary celiac disease

&
Pages 767-780 | Published online: 10 Jan 2014

References

  • West J, Logan RF, Hill PG et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut52(7), 960–965 (2003).
  • Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology123(5), 1428–1435 (2002).
  • Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol. Ther.20(7), 769–775 (2004).
  • Logan RF, Rifkind EA, Turner ID, Ferguson A. Mortality in celiac disease. Gastroenterology97(2), 265–271 (1989).
  • Silano M, Volta U, Mecchia AM, Dessi M, Di Benedetto R, de Vincenzi M; Collaborating centers of the Italian registry of the complications of coeliac disease. Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol.7, 8 (2007).
  • Solaymani-Dodaran M, West J, Logan RF. Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study. Am. J. Gastroenterol.102(4), 864–870 (2007).
  • West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ329(7468), 716–719 (2004).
  • Lewis NR, Sanders DS, Logan RF, Fleming KM, Hubbard RB, West J. Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment. Br. J. Nutr.102(4), 509–513 (2009).
  • Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol. Ther.24(1), 47–54 (2006).
  • Holmes GK. To determine the incidence and prevalence of adult coeliac disease in Derby city. Gut58(Suppl. 2), A409 (2009).
  • Collin P, Huhtala H, Virta L, Kekkonen L, Reunala T. Diagnosis of celiac disease in clinical practice: physician’s alertness to the condition essential. J. Clin. Gastroenterol.41(2), 152–156 (2007).
  • Lohi S, Mustalahti K, Kaukinen K et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol. Ther.26(9), 1217–1225 (2007).
  • Feighery C. Fortnightly review: coeliac disease. BMJ319(7204), 236–239 (1999).
  • Sollid LM. Molecular basis of celiac disease. Annu. Rev. Immunol.1853–1881 (2000).
  • Korponay-Szabo IR, Halttunen T, Szalai Z et al.In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut53(5), 641–648 (2004).
  • Naiyer AJ, Shah J, Hernandez L et al. Tissue transglutaminase antibodies in individuals with celiac disease bind to thyroid follicles and extracellular matrix and may contribute to thyroid dysfunction. Thyroid18(11), 1171–1178 (2008).
  • Drago S, El Asmar R, Di Pierro M et al. Gliadin, zonulin and gut permeability: effects on celiac and nonceliac intestinal mucosa and intestinal cell lines. Scand. J. Gastroenterol.41(4), 408–419 (2006).
  • Rose NR. Autoimmune diseases: tracing the shared threads. Hosp. Pract. (Minneap.)32(4), 147–154 (1997).
  • Zhong F, McCombs CC, Olson JM et al. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat. Genet.14(3), 329–333 (1996).
  • Satsangi J, Parkes M, Louis E et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat. Genet.14(2), 199–202 (1996).
  • Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc. Natl Acad. Sci. USA95(25), 14875–14879 (1998).
  • Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am. J. Pathol.151(2), 493–498 (1997).
  • Ludvigsson JF, Ludvigsson J, Ekbom A, Montgomery SM. Celiac disease and risk of subsequent Type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care29(11), 2483–2488 (2006).
  • Holmes GK. Screening for coeliac disease in Type 1 diabetes. Arch. Dis. Child.87(6), 495–498 (2002).
  • Hansen D, Brock-Jacobsen B, Lund E et al. Clinical benefit of a gluten-free diet in Type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years’ follow-up. Diabetes Care29(11), 2452–2456 (2006).
  • Larsson K, Carlsson A, Cederwall E et al. Annual screening detects celiac disease in children with Type 1 diabetes. Pediatr. Diabetes9(4 Pt 2), 354–359 (2008).
  • Holmes GK. Coeliac disease and Type 1 diabetes mellitus – the case for screening. Diabet. Med.18(3), 169–177 (2001).
  • Narula P, Porter L, Langton J et al. Gastrointestinal symptoms in children with Type 1 diabetes screened for celiac disease. Pediatrics124(3), E489–E495 (2009).
  • Sanchez-Albisua I, Wolf J, Neu A, Geiger H, Wascher I, Stern M. Coeliac disease in children with Type 1 diabetes mellitus: the effect of the gluten-free diet. Diabet. Med.22(8), 1079–1082 (2005).
  • Goh C, Banerjee K. Prevalence of coeliac disease in children and adolescents with Type 1 diabetes mellitus in a clinic based population. Postgrad. Med. J.83(976), 132–136 (2007).
  • Frohlich-Reiterer EE, Hofer S, Kaspers S et al. Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with Type 1 diabetes mellitus – data from a German/Austrian multicentre survey. Pediatr. Diabetes9(6), 546–553 (2008).
  • Hadithi M, de Boer H, Meijer JW et al. Coeliac disease in Dutch patients with Hashimoto’s thyroiditis and vice versa. World J. Gastroenterol.13(11), 1715–1722 (2007).
  • Sategna-Guidetti C, Volta U, Ciacci C et al. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am. J. Gastroenterol.96(3), 751–757 (2001).
  • Elfstrom P, Montgomery SM, Kampe O, Ekbom A, Ludvigsson JF. Risk of thyroid disease in individuals with celiac disease. J. Clin. Endocrinol. Metab.93(10), 3915–3921 (2008).
  • Meloni A, Mandas C, Jores RD, Congia M. Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J. Pediatr.155(1), 51–55 (2009).
  • Sari S, Yesilkaya E, Egritas O, Bideci A, Dalgic B. Prevalence of celiac disease in Turkish children with autoimmune thyroiditis. Dig. Dis. Sci.54(4), 830–832 (2009).
  • Lawson A, West J, Aithal GP, Logan RF. Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Aliment Pharmacol. Ther.21(4), 401–405 (2005).
  • Ludvigsson JF, Elfstrom P, Broome U, Ekbom A, Montgomery SM. Celiac disease and risk of liver disease: a general population-based study. Clin. Gastroenterol. Hepatol.5(1), 63–69, e1 (2007).
  • Lewis NR, Sanders DS, Teahon K, Logan RFA, Fleming KM, West J. Prevalence and consequence of hypertransaminasemia in incident coeliac disease; how common is it and does it matter? Gut58(Suppl. 1), A6 (2009).
  • Maggiore G, Caprai S. The liver in celiac disease. J. Pediatr. Gastroenterol. Nutr.37(2), 117–119 (2003).
  • Elfstrom P, Montgomery SM, Kampe O, Ekbom A, Ludvigsson JF. Risk of primary adrenal insufficiency in patients with celiac disease. J. Clin. Endocrinol. Metab.92(9), 3595–3598 (2007).
  • Olen O, Montgomery SM, Elinder G, Ekbom A, Ludvigsson JF. Increased risk of immune thrombocytopenic purpura among inpatients with coeliac disease. Scand. J. Gastroenterol.43(4), 416–422 (2008).
  • Birkenfeld S, Dreiher J, Weitzman D, Cohen AD. Coeliac disease associated with psoriasis. Br. J. Dermatol.161(6), 1331–1334 (2009).
  • Neuhausen SL, Steele L, Ryan S et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J. Autoimmun.31(2), 160–165 (2008).
  • Patinen P, Aine L, Collin P et al. Oral findings in coeliac disease and Sjogren’s syndrome. Oral Dis.10(6), 330–334 (2004).
  • Maida MJ, Praveen E, Crimmins SR, Swift GL. Coeliac disease and primary hyperparathyroidism: an association? Postgrad. Med. J.82(974), 833–835 (2006).
  • Kohler S, Wass JA. Hypoparathyroidism and coeliac disease: a potentially dangerous combination. J. R. Soc. Med.102(8), 311–314 (2009).
  • Collin P, Hakanen M, Salmi J, Maki M, Kaukinen K. Autoimmune hypopituitarism in patients with coeliac disease: symptoms confusingly similar. Scand. J. Gastroenterol.36(5), 558–560 (2001).
  • Song MS, Farber D, Bitton A, Jass J, Singer M, Karpati G. Dermatomyositis associated with celiac disease: response to a gluten-free diet. Can. J. Gastroenterol.20(6), 433–435 (2006).
  • Zeglaoui H, Landolsi H, Mankai A, Ghedira I, Bouajina E. Type 1 diabetes mellitus, celiac disease, systemic lupus erythematosus and systemic scleroderma in a 15-year-old girl. Rheumatol. Int.30(6), 793–795 (2009).
  • Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch. Intern. Med.163(13), 1566–1572 (2003).
  • Whorwell PJ, Alderson MR, Foster KJ, Wright R. Death from ischaemic heart-disease and malignancy in adult patients with coeliac disease. Lancet2(7977), 113–114 (1976).
  • Corrao G, Corazza GR, Bagnardi V et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet358(9279), 356–361 (2001).
  • Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L, Granath F. Small-intestinal histopathology and mortality risk in celiac disease. JAMA302(11), 1171–1178 (2009).
  • West J, Logan RF, Card TR, Smith C, Hubbard R. Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study. Aliment Pharmacol. Ther.20(1), 73–79 (2004).
  • Austin AS, Logan RF, Thomason K, Holmes GK. Cigarette smoking and adult coeliac disease. Scand. J. Gastroenterol.37(8), 978–982 (2002).
  • Patel AH, Loftus EV Jr, Murray JA, Harmsen WS, Zinsmeister AR, Sandborn WJ. Cigarette smoking and celiac sprue: a case–control study. Am. J. Gastroenterol.96(8), 2388–2391 (2001).
  • Snook JA, Dwyer L, Lee-Elliott C, Khan S, Wheeler DW, Nicholas DS. Adult coeliac disease and cigarette smoking. Gut39(1), 60–62 (1996).
  • Ludvigsson JF, Montgomery SM, Ekbom A. Smoking and celiac disease: a population-based cohort study. Clin. Gastroenterol. Hepatol.3(9), 869–874 (2005).
  • Dickey W, Ward M, Whittle CR et al. Homocysteine and related B-vitamin status in coeliac disease: effects of gluten exclusion and histological recovery. Scand. J. Gastroenterol.43(6), 682–688 (2008).
  • Ludvigsson JF, de Faire U, Ekbom A, Montgomery SM. Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease. Heart93(9), 1111–1115 (2007).
  • Wei L, Spiers E, Reynolds N, Walsh S, Fahey T, MacDonald TM. The association between coeliac disease and cardiovascular disease. Aliment Pharmacol. Ther.27(6), 514–519 (2008).
  • Ciacci C, Cirillo M, Giorgetti G et al. Low plasma cholesterol: a correlate of nondiagnosed celiac disease in adults with hypochromic anemia. Am. J. Gastroenterol.94(7), 1888–1891 (1999).
  • Fonager K, Sorensen HT, Norgard B, Thulstrup AM. Cardiomyopathy in Danish patients with coeliac disease. Lancet354(9189), 1561 (1999).
  • Elfstrom P, Hamsten A, Montgomery SM, Ekbom A, Ludvigsson JF. Cardiomyopathy, pericarditis and myocarditis in a population-based cohort of inpatients with coeliac disease. J. Intern. Med.262(5), 545–554 (2007).
  • Catassi C, Fabiani E, Corrao G et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA287(11), 1413–1419 (2002).
  • Cooper BT, Holmes GK, Ferguson R, Cooke WT. Celiac disease and malignancy. Medicine (Baltimore)59(4), 249–261 (1980).
  • Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease – effect of a gluten free diet. Gut30(3), 333–338 (1989).
  • West J, Logan RFA, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ329(7468), 716–719 (2004).
  • Anderson LA, McMillan SA, Watson RG et al. Malignancy and mortality in a population-based cohort of patients with coeliac disease or ‘gluten sensitivity’. World J. Gastroenterol.13(1), 146–151 (2007).
  • Gao Y, Kristinsson SY, Goldin LR, Bjorkholm M, Caporaso NE, Landgren O. Increased risk for nonHodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology136(1), 91–98 (2009).
  • Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Jewell D. Cancer in patients with ulcerative colitis, Crohn’s disease and coeliac disease: record linkage study. Eur. J. Gastroenterol. Hepatol.20(4), 297–304 (2008).
  • Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology128(4 Suppl. 1), S79–S86 (2005).
  • Lewis NR, Logan RFA, Sanders DS, Holmes GKT, West J. Reproductive and hormonal factors for breast cancer among women with coeliac disease; a population-based questionnaire study. Gut58(Suppl. 2), A413 (2009).
  • Michels KB, Ekbom A. Caloric restriction and incidence of breast cancer. JAMA291(10), 1226–1230 (2004).
  • Howdle PD, Jalal PK, Holmes GK, Houlston RS. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM96(5), 345–353 (2003).
  • Farre C, Domingo-Domenech E, Font R et al. Celiac disease and lymphoma risk: a multicentric case–control study in Spain. Dig. Dis. Sci.49(3), 408–412 (2004).
  • Mearin ML, Catassi C, Brousse N et al. European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Eur. J. Gastroenterol. Hepatol.18(2), 187–194 (2006).
  • Lohi S, Maki M, Montonen J et al. Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut58(5), 643–647 (2009).
  • Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology119(1), 243–251 (2000).
  • Fine KD, Meyer RL, Lee EL. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology112(6), 1830–1838 (1997).
  • Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin. Gastroenterol. Hepatol.5(4), 445–450 (2007).
  • Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am. J. Gastroenterol.95(3), 712–714 (2000).
  • Cellier C, Delabesse E, Helmer C et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet356(9225), 203–208 (2000).
  • Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut56(10), 1373–1378 (2007).
  • Malamut G, Afchain P, Verkarre V et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology136(1), 81–90 (2009).
  • Meijers JWR, Mulder C, Goerres MG et al. Coeliac disease and (extra) intestinal T-cell lymphoma. Scand. J. Gastroenterol.241, 78–84 (2004).
  • Patey-Mariaud De Serre N, Cellier C, Jabri B et al. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology37(1), 70–77 (2000).
  • Mulder CJJ, Wahab P. Moshaver B et al. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma. Scand. J. Gastroenterol.S232, 32–37 (2000).
  • Lewis NR, Scott BB. Guidelines on Osteoporosis in Coeliac Disease and Inflammatory Bowel Disease. British Society of Gastroenterology, Glasgow, UK (2007).
  • Kanis JA, Johnell O, Oden A, Dawson A, de Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos. Int.12(12), 989–995 (2001).
  • Valdimarsson T, Lofman O, Toss G, Strom M. Reversal of osteopenia with diet in adult coeliac disease. Gut38(3), 322–327 (1996).
  • McFarlane XA, Bhalla AK, Robertson DA. Effect of a gluten free diet on osteopenia in adults with newly diagnosed coeliac disease. Gut39(2), 180–184 (1996).
  • Espallargues M, Sampietro-Colom L, Estrada MD et al. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos. Int.12(10), 811–822 (2001).
  • Hodkinson HM, McPherson CK. Alkaline phosphatase in a geriatric inpatient population. Age Ageing2(1), 28–33 (1973).
  • Peach H, Compston JE, Vedi S, Horton LW. Value of plasma calcium, phosphate, and alkaline phosphatase measurements in the diagnosis of histological osteomalacia. J. Clin. Pathol.35(6), 625–630 (1982).
  • Kemppainen T, Kroger H, Janatuinen E et al. Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone25(3), 355–360 (1999).
  • Sategna-Guidetti C, Grosso SB, Grosso S et al. The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol. Ther.14(1), 35–43 (2000).
  • Holmes GKT. Neurological and psychiatric complications in coeliac disease. In: Epilepsy and Other Neurological Disorders in Coeliac Disease. Gobbi G, Andermann F, Nacarrato S, Banchini G (Eds). John Libbey and Company Ltd., London, UK, 251–264 (1997).
  • Ludvigsson JF, Olsson T, Ekbom A, Montgomery SM. A population-based study of coeliac disease, neurodegenerative and neuroinflammatory diseases. Aliment Pharmacol. Ther.25(11), 1317–1327 (2007).
  • Finelli PF, McEntee WJ, Ambler M, Kestenbaum D. Adult celiac disease presenting as cerebellar syndrome. Neurology30(3), 245–249 (1980).
  • Pengiran Tengah DS, Wills AJ, Holmes GKT. Neurological complications of coeliac disease. Postgrad. Med. J.78(921), 393–398 (2002).
  • Ludvigsson JF, Reutfors J, Osby U, Ekbom A, Montgomery SM. Coeliac disease and risk of mood disorders – a general population-based cohort study. J. Affect. Disord.99(1–3), 117–126 (2007).
  • Garud S, Leffler D, Dennis M et al. Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the Northeastern United States. Aliment Pharmacol. Ther.29(8), 898–905 (2009).
  • Pynnonen PA, Isometsa ET, Verkasalo MA et al. Gluten-free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: a prospective follow-up case-series study. BMC Psychiatry5, 14 (2005).
  • Roos S, Karner A, Hallert C. Psychological well-being of adult coeliac patients treated for 10 years. Dig. Liver Dis.38(3), 177–180 (2006).
  • Hallert C, Svensson M, Tholstrup J, Hultberg B. Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet. Aliment Pharmacol. Ther.29(8), 811–816 (2009).
  • Dalgic B, Dursun I, Serdaroglu A, Dursun A. Latent and potential celiac disease in epileptic Turkish children. J. Child Neurol.21(1), 6–7 (2006).
  • Pengiran Tengah DS, Holmes GK, Wills AJ. The prevalence of epilepsy in patients with celiac disease. Epilepsia45(10), 1291–1293 (2004).
  • Gobbi G, Bouquet F, Greco L et al. Coeliac disease, epilepsy, and cerebral calcifications. The Italian Working Group on Coeliac Disease and Epilepsy. Lancet340(8817), 439–443 (1992).
  • Peltola M, Kaukinen K, Dastidar P et al. Hippocampal sclerosis in refractory temporal lobe epilepsy is associated with gluten sensitivity. J. Neurol. Neurosurg. Psychiatry80(6), 626–630 (2009).
  • Gabrielli M, Cremonini F, Fiore G et al. Association between migraine and Celiac disease: results from a preliminary case–control and therapeutic study. Am. J. Gastroenterol.98(3), 625–629 (2003).
  • Zelnik N, Pacht A, Obeid R, Lerner A. Range of neurologic disorders in patients with celiac disease. Pediatrics113(6), 1672–1676 (2004).
  • Eaton W, Mortensen PB, Agerbo E, Byrne M, Mors O, Ewald H. Coeliac disease and schizophrenia: population based case–control study with linkage of Danish national registers. BMJ328(7437), 438–439 (2004).
  • West J, Logan RF, Hubbard RB, Card TR. Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn’s disease: a general population-based study. Aliment Pharmacol. Ther.23(1), 71–74 (2006).
  • Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA. Cognitive impairment and celiac disease. Arch. Neurol.63(10), 1440–1446 (2006).
  • Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet347(8998), 369–371 (1996).
  • Hadjivassiliou M, Grunewald RA, Kandler RH et al. Neuropathy associated with gluten sensitivity. J. Neurol. Neurosurg. Psychiatry77(11), 1262–1266 (2006).
  • Hadjivassiliou M, Sanders DS, Woodroofe N, Williamson C, Grunewald RA. Gluten ataxia. Cerebellum7(3), 494–498 (2008).
  • Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann. Neurol.49(4), 540–543 (2001).
  • Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann. Neurol.64(3), 332–343 (2008).
  • Rostami K, Steegers EA, Wong WY, Braat DD, Steegers-Theunissen RP. Coeliac disease and reproductive disorders: a neglected association. Eur. J. Obstet. Gynecol. Reprod. Biol.96146–96149 (2001).
  • Green PH, Jabri B. Coeliac disease. Lancet362(9381), 383–391 (2003).
  • Ciacci C, Cirillo M, Auriemma G, di Dato G, Sabbatini F, Mazzacca G. Celiac disease and pregnancy outcome. Am. J. Gastroenterol.91(4), 718–722 (1996).
  • Martinelli P, Troncone R, Paparo F et al. Coeliac disease and unfavourable outcome of pregnancy. Gut46(3), 332–335 (2000).
  • Meloni GF, Dessole S, Vargiu N, Tomasi PA, Musumeci S. The prevalence of coeliac disease in infertility. Hum. Reprod.14(11), 2759–2761 (1999).
  • Norgard B, Fonager K, Sorensen HT, Olsen J. Birth outcomes of women with celiac disease: a nationwide historical cohort study. Am. J. Gastroenterol.94(9), 2435–2440 (1999).
  • Sher KS, Mayberry JF. Female fertility, obstetric and gynaecological history in coeliac disease: a case–control study. Acta Paediatr.412(Suppl.), 76–77 (1996).
  • Smecuol E, Maurino E, Vazquez H et al. Gynaecological and obstetric disorders in coeliac disease: frequent clinical onset during pregnancy or the puerperium. Eur. J. Gastroenterol. Hepatol.8(1), 63–89 (1996).
  • Tata LJ, Card TR, Logan RF, Hubbard RB, Smith CJ, West J. Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study. Gastroenterology128(4), 849–855 (2005).
  • Lewis NR, Logan RSD, Holmes G, West J. Fertility and pregnancy related events in women with coeliac disease: a population based questionnaire. Gut58(Suppl. 2), A412 (2009).
  • Khashan AS, Henriksen TB, Mortensen PB et al. The impact of maternal celiac disease on birthweight and preterm birth: a Danish population-based cohort study. Hum. Reprod.25(2), 528–534 (2010).
  • British Committee for Standards in Haematology. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ312(7028), 430–434 (1996).
  • Thomsen RW, Schoonen WM, Farkas DK et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann. Intern. Med.151(8), 546–555 (2009).
  • Baker PG, Jones JV, Peacock DB, Read AE. The immune response of phiX 174 in man. III. Evidence for an association between hyposplenism and immunodeficiency in patients with coeliac disease. Gut16(7), 538–542 (1975).
  • Corazza GR, Frisoni M, Vaira D, Gasbarrini G. Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut24(3), 228–230 (1983).
  • Corazza GR, Lazzari R, Frisoni M, Collina A, Gasbarrini G. Splenic function in childhood coeliac disease. Gut23(5), 415–416 (1982).
  • Corazza GR, Zoli G, Di Sabatino A, Ciccocioppo R, Gasbarrini G. A reassessment of splenic hypofunction in celiac disease. Am. J. Gastroenterol.94(2), 391–397 (1999).
  • Croese J, Harris O, Bain B. Coeliac disease. Haematological features, and delay in diagnosis. Med. J. Aust.2(7), 335–338 (1979).
  • Di Sabatino A, Rosado MM, Cazzola P et al. Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Clin. Gastroenterol. Hepatol.4(2), 179–186 (2006).
  • Marsh GW, Stewart JS. Splenic function in adult coeliac disease. Br. J. Haematol.19(4), 445–457 (1970).
  • McCarthy CF, Fraser ID, Evans KT, Read AE. Lymphoreticular dysfunction in idiopathic steatorrhoea. Gut7(2), 140–148 (1966).
  • O’Grady JG, Stevens FM, Harding B, O’Gorman TA, McNicholl B, McCarthy CF. Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence, and relationship to diet and small bowel morphology. Gastroenterology87(6), 1326–1331 (1984).
  • O’Grady JG, Stevens FM, McCarthy CF. Genetic influences on splenic function in coeliac disease. Gut26(10), 1004–1007 (1985).
  • Robertson DA, Swinson CM, Hall R, Losowsky MS. Coeliac disease, splenic function, and malignancy. Gut23(8), 666–669 (1982).
  • Robinson PJ, Bullen AW, Hall R, Brown RC, Baxter P, Losowsky MS. Splenic size and function in adult coeliac disease. Br. J. Radiol.53(630), 532–537 (1980).
  • Trewby PN, Chipping PM, Palmer SJ, Roberts PD, Lewis SM, Stewart JS. Splenic atrophy in adult coeliac disease: is it reversible? Gut22(8), 628–632 (1981).
  • Ludvigsson JF, Olen O, Bell M, Ekbom A, Montgomery SM. Coeliac disease and risk of sepsis. Gut57(8), 1074–1080 (2008).
  • Department of Health United Kingdom. Immunisation Against Infectious Diseases – The Green Book.25, 295–313 (2010)
  • Pebody RG, Hippisley-Cox J, Harcourt S, Pringle M, Painter M, Smith G. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999–2005. Epidemiol Infect.136(3), 360–369 (2008).
  • Yang A, Chen Y, Scherl E, Neugut AI, Bhagat G, Green PH. Inflammatory bowel disease in patients with celiac disease. Inflamm. Bowel Dis.11(6), 528–532 (2005).
  • Leeds JS, Horoldt BS, Sidhu R et al. Is there an association between coeliac disease and inflammatory bowel diseases? A study of relative prevalence in comparison with population controls. Scand. J. Gastroenterol.42(10), 1214–1220 (2007).
  • Casella G, D’Inca R, Oliva L et al. Prevalence of celiac disease in inflammatory bowel diseases: an IG-IBD multicentre study. Dig Liver Dis.42(3), 175–178 (2010).
  • Green PH, Yang J, Cheng J, Lee AR, Harper JW, Bhagat G. An association between microscopic colitis and celiac disease. Clin. Gastroenterol. Hepatol.7(11), 1210–1216 (2009).
  • Dickey W. A case of sequential development of celiac disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol.4(8), 463–467 (2007).
  • Jadallah KA, Khader YS. Celiac disease in patients with presumed irritable bowel syndrome: a case-finding study. World J. Gastroenterol.15(42), 5321–5325 (2009).
  • Sanders D. Irritable bowel syndrome and coeliac disease. Lancet359(9315), 1436–1437 (2002).
  • Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch. Intern. Med.169(7), 651–658 (2009).
  • Wahnschaffe U, Schulzke JD, Zeitz M, Ullrich R. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin. Gastroenterol. Hepatol.5(7), 844–850 (2007).
  • Ludvigsson JF, Montgomery SM, Ekbom A. Risk of pancreatitis in 14,000 individuals with celiac disease. Clin. Gastroenterol. Hepatol.5(11), 1347–1353 (2007).
  • Eapen CE, Nightingale P, Hubscher SG et al. Noncirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig. Dis. Sci. DOI: 10.1007/s10620-010-1278-2 (2010) (Epub ahead of print).
  • Procaccini M, Campisi G, Bufo P et al. Lack of association between celiac disease and dental enamel hypoplasia in a case–control study from an Italian central region. Head Face Med.3, 25 (2007).
  • Avsar A, Kalayci AG. The presence and distribution of dental enamel defects and caries in children with celiac disease. Turk. J. Pediatr.50(1), 45–50 (2008).
  • Cheng J, Malahias T, Brar P, Minaya MT, Green PH. The association between celiac disease, dental enamel defects, and aphthous ulcers in a United States cohort. J. Clin. Gastroenterol.44(3), 191–194 (2010).
  • Wierink CD, van Diermen DE, Aartman IH, Heymans HS. Dental enamel defects in children with coeliac disease. Int. J. Paediatr. Dent.17(3), 163–168 (2007).
  • Bucci P, Carile F, Sangianantoni A, D’Angio F, Santarelli A, Lo Muzio L. Oral aphthous ulcers and dental enamel defects in children with coeliac disease. Acta Paediatr.95(2), 203–207 (2006).
  • Shakeri R, Zamani F, Sotoudehmanesh R et al. Gluten sensitivity enteropathy in patients with recurrent aphthous stomatitis. BMC Gastroenterol.9, 44 (2009).
  • Campisi G, Di Liberto C, Carroccio A et al. Coeliac disease: oral ulcer prevalence, assessment of risk and association with gluten-free diet in children. Dig. Liver Dis.40(2), 104–107 (2008).
  • Wouters J, Weijerman ME, van Furth AM et al. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome. J. Pediatr.154(2), 239–242 (2009).
  • Giannotti A, Tiberio G, Castro M et al. Coeliac disease in Williams syndrome. J. Med. Genet.38(11), 767–768 (2001).
  • Frost AR, Band MM, Conway GS. Serological screening for coeliac disease in adults with Turner’s syndrome: prevalence and clinical significance of endomysium antibody positivity. Eur. J. Endocrinol.160(4), 675–679 (2009).
  • Sagodi L, Solyom E, Tamasi K, Minik K. [Prevalence of celiac disease in Turner syndrome]. Orv. Hetil.147(25), 1185–1188 (2006).
  • Fluge G, Olesen HV, Gilljam M et al. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients. J. Cyst. Fibros.8(3), 198–202 (2009).
  • Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM. Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax62(1), 23–28 (2007).
  • Ludvigsson JF, Welander A, Lassila R, Ekbom A, Montgomery SM. Risk of thromboembolism in 14,000 individuals with coeliac disease. Br. J. Haematol.139(1), 121–127 (2007).
  • Hwang E, McBride R, Neugut AI, Green PH. Sarcoidosis in patients with celiac disease. Dig. Dis. Sci.53(4), 977–981 (2008).
  • Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM. Coeliac disease and risk of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis.24(2), 121–126 (2007).
  • Rutherford RM, Brutsche MH, Kearns M, Bourke M, Stevens F, Gilmartin JJ. Prevalence of coeliac disease in patients with sarcoidosis. Eur. J. Gastroenterol. Hepatol.16(9), 911–915 (2004).
  • Fry L. Dermatitis herpetiformis. Baillieres Clin. Gastroenterol.9(2), 371–393 (1995).
  • Lewis NR, Logan RF, Hubbard RB, West J. No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Aliment Pharmacol. Ther.27(11), 1140–1147 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.